Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116)
- PMID: 1328688
- PMCID: PMC240171
- DOI: 10.1128/JVI.66.11.6747-6754.1992
Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116)
Abstract
The disulfide-linked glycoprotein B (gB; gp55-116) complex of human cytomegalovirus represents the most abundant and immunogenic component of the virion envelope. We have studied the oligomerization and transport of this molecule, using a series of murine monoclonal antibodies. Our results indicated that oligomerization of this molecule occurred shortly after its synthesis, with a half-time of maximal formation of approximately 25 min. The oligomeric form had an estimated mass of 340,000 Da and likely consisted of a homodimer of the gp55-116 complex. By using a conformation-specific monoclonal antibody, postoligomerization folding of this molecule was demonstrated. This event exhibited an unusually prolonged half-maximal time of approximately 160 min. Both oligomerization and folding occurred in the endoplasmic reticulum. Oligomerization and folding occurred in the absence of carbohydrate modifications, although likely at lower efficiency. Finally, the oligomeric and folded forms were shown to be transported to the surface of infected cells and infectious virions.
Similar articles
-
Postoligomerization folding of human cytomegalovirus glycoprotein B: identification of folding intermediates and importance of disulfide bonding.J Virol. 1995 Nov;69(11):7015-22. doi: 10.1128/JVI.69.11.7015-7022.1995. J Virol. 1995. PMID: 7474121 Free PMC article.
-
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus.J Virol. 1989 Jan;63(1):403-10. doi: 10.1128/JVI.63.1.403-410.1989. J Virol. 1989. PMID: 2535741 Free PMC article.
-
Calnexin acts as a molecular chaperone during the folding of glycoprotein B of human cytomegalovirus.J Virol. 1996 Apr;70(4):2237-46. doi: 10.1128/JVI.70.4.2237-2246.1996. J Virol. 1996. PMID: 8642648 Free PMC article.
-
Synthesis and processing of the envelope gp55-116 complex of human cytomegalovirus.J Virol. 1986 Apr;58(1):185-91. doi: 10.1128/JVI.58.1.185-191.1986. J Virol. 1986. PMID: 3005648 Free PMC article.
-
A Native Human Monoclonal Antibody Targeting HCMV gB (AD-2 Site I).Int J Mol Sci. 2018 Dec 11;19(12):3982. doi: 10.3390/ijms19123982. Int J Mol Sci. 2018. PMID: 30544903 Free PMC article. Review.
Cited by
-
Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture.J Virol. 2002 Feb;76(3):1252-64. doi: 10.1128/jvi.76.3.1252-1264.2002. J Virol. 2002. PMID: 11773401 Free PMC article.
-
Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response.Vaccine. 2018 Sep 5;36(37):5580-5590. doi: 10.1016/j.vaccine.2018.07.056. Epub 2018 Aug 3. Vaccine. 2018. PMID: 30082162 Free PMC article.
-
Receptor-binding properties of a soluble form of human cytomegalovirus glycoprotein B.J Virol. 1998 Mar;72(3):1826-33. doi: 10.1128/JVI.72.3.1826-1833.1998. J Virol. 1998. PMID: 9499033 Free PMC article.
-
Conservation of the glycoprotein B homologs of the Kaposi׳s sarcoma-associated herpesvirus (KSHV/HHV8) and old world primate rhadinoviruses of chimpanzees and macaques.Virology. 2016 Jul;494:29-46. doi: 10.1016/j.virol.2016.04.003. Epub 2016 Apr 11. Virology. 2016. PMID: 27070755 Free PMC article.
-
THY-1 Cell Surface Antigen (CD90) Has an Important Role in the Initial Stage of Human Cytomegalovirus Infection.PLoS Pathog. 2015 Jul 6;11(7):e1004999. doi: 10.1371/journal.ppat.1004999. eCollection 2015 Jul. PLoS Pathog. 2015. PMID: 26147640 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources